/PRNewswire/ - Medunik USA, member of Duchesnay Pharmaceutical Group (DPG) one of the few anchor companies selected by the Government of Canada for its Global.
SIKLOS® (hydroxyurea) is now covered by State Medicaid programs in 19 states streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ The urea cycle disorder treatment market size is expected to grow by USD 235.5 million from 2022 to 2027. In addition, the momentum of the.
Pheburane® Now on the Preferred Drug List in 6 states and included on the Contract Drug List in California. PRINCETON, N.J., Aug. 09, 2023 (GLOBE NEWSWIRE) Medunik USA (member of Duchesnay Pharmaceutical Group) is pleased to announce that an increasing number of Americans with certain urea cycle disorders (UCDs) now have access to Pheburane® (sodium phenylbutyrate) through a rapidly expanding network of key pharmacy benefit managers (PBMs), state Medicaid programs or Managed Medicaid plans. S